Webinars

Fast Forward to Next Generation Imaging - The Leica Biosystems Solution Bringing Your Digital Pathology to the Next Level.
The Cutting-Edge Technology of AI Prostate Cancer Diagnosis in the Era of Digital Pathology
Digital Pathology for Primary Diagnosis from an IT Manager's perspective
  • Mark Flood, BMLSc ,
    Application Specialist, Pathology Associates, Pathlab Bay of Plenty, New Zealand
How Integration Helps to Adopt Digital Pathology
Demystifying DICOM in Digital Pathology: Experiences from the National Pathology Imaging Co-operative
Experience Next Generation Imaging - Leica Biosystems latest Digital Pathology solution built with pathologist in mind
COVID-19 Response and the (Remote) Use of Digital Pathology
The Value of an RTU

The Value of an RTU

Novocastra p16 Antibody Demonstrated an Agreement of 98% with the Roche p16 Antibody

Novocastra p16 antibody demonstrated an agreement of 98% with the Roche p16 antibody The study compared the percentage agreement rates of Novocastra’s p16 (6H12) IVD solution with Roche CINtec® Histology p16 assay on 170 oropharyngeal cancer cases.

How to dramatically reduce your IHC staining times with the Leica Biosystems BOND-III

NEW STUDY SHOWS BOND-III UP TO 40% FASTER THAN BENCHMARK ULTRA In a recent study, the Leica Biosystems BOND-III was found to complete cases up to 100 minutes faster than the Roche Tissue Diagnostics BenchMark ULTRA. The study examines the panel turnaround...